Q1 2019 13F Holders as of 31 Mar 2019
-
Type / Class
-
Equity / COM
-
Total 13F shares
-
19,612,110
-
Share change
-
+66,350
-
Total reported value
-
$666,815,358
-
Price per share
-
$34.00
-
Number of holders
-
61
-
Value change
-
+$20,204,176
-
Number of buys
-
28
-
Number of sells
-
24
Institutional Holders of PRINCIPIA BIOPHARMA INC - COM (PRNB) as of Q1 2019
As of 31 Mar 2019,
PRINCIPIA BIOPHARMA INC - COM (PRNB) was held by
61 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
19,612,110 shares.
The largest 10 holders included
FMR LLC, New Leaf Venture Partners, L.L.C., ORBIMED ADVISORS LLC, Sofinnova Investments, Inc., BAKER BROS. ADVISORS LP, Cormorant Asset Management, LP, PRICE T ROWE ASSOCIATES INC /MD/, ADAGE CAPITAL PARTNERS GP, L.L.C., RTW INVESTMENTS, LP, and BlackRock Inc..
This page lists
61
institutional shareholders reporting positions in this security
for the Q1 2019 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.